JP Stock MarketDetailed Quotes

4512 Wakamoto Pharmaceutical

Watchlist
  • 224
  • -1-0.44%
20min DelayNot Open Jan 7 15:30 JST
7.80BMarket Cap71.57P/E (Static)

Wakamoto Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Wakamoto Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 2, 20242025/Q11.884B / ----
Feb 5, 20242024/Q31.968B / ----
Aug 4, 20232024/Q11.860B / ----
Feb 2, 20232023/Q32.248B / ----
Aug 4, 20222023/Q12.023B / ----
DatePeriodRevenue/EstimateEarnings Call
Aug 2, 20242025/Q11.884B / ----
Feb 5, 20242024/Q31.968B / ----
Aug 4, 20232024/Q11.860B / ----
Feb 2, 20232023/Q32.248B / ----
Aug 4, 20222023/Q12.023B / ----

Unlock Free Earnings Estimates

Wakamoto Pharmaceutical Earnings Reports

  • Wakamoto Pharmaceutical: Confirmation letter

    Nov 12, 2024 19:51 ET

  • Wakamoto Pharmaceutical: Half Year Report - Term 130 (2024/04/01 - 2025/03/31)

    Nov 12, 2024 19:46 ET

  • Wakamoto Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (unconsolidated)

    Nov 6, 2024 01:30 ET

  • Wakamoto Pharmaceutical: FY2025 Q1 financial statement (Japan standard, non-consolidated)

    Aug 2, 2024 02:00 ET

    • Read more

    Heat List
    JP
    Overall
    Symbol
    Price
    % Chg

    No Data